Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC—opportunities and obstacles

Benzer Materyaller

• Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
  Yazar:: Attili, Ilaria, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Does TMB impact the effectiveness of TKIs in EGFR-mutant NSCLC?
  Yazar:: Cheng, Michael L., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis
  Yazar:: Lin, Chutong, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
  Yazar:: Wen, Miaomiao, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
  Yazar:: Wei, Zhigang, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)